- Lobbying
- pharmaceutical AND industry AND labor AND management
Lobbying Arrangements Results for 'Pharmaceutical Industry Labor Management'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally |
Pharmaceutical Industry Labor Management Association
|
GrossmanHeinz | |||
Details Patent Reform Legislation |
Pharmaceutical Industry Labor-Management Association
|
Mr. Gerald Baker | |||
Details No Free TRIPS Act (H.R. 3858) - Strongly oppose expanding the TRIPS Waiver as it would endanger American Jobs without improving global health. |
Pharmaceutical Industry Labor Management Association
|
DAVE KOLBE CONSULTING | |||
Details Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally. S.1339 - 118th Congress (2023-... |
Pharmaceutical Industry Labor-Management Association
|
Mr. Christopher Heinz | |||
Details Promote skilled craft labor, domestic manufacturing, and innovation in the life sciences industry. |
Pharmaceutical Industry Labor-Management Association
Facilitates a dialogue between unions and the pharmaceutical industry on issues. |
MCCARTER & ENGLISH, LLP | |||
Details Any and all legislation affecting the pharmaceutical industry |
Pharmaceutical Industry Labor-Management Association
Labor-management association for the pharmaceutical industry |
Leary Ventures | |||
Details Federal issues impacting workforce and innovation in the pharmaceutical industry. |
Pharmaceutical Industry Labor Management Association (PILMA
|
Dentons US LLP | |||
Details Drug importation Price controls Pharmacy Benefit Manager issues |
Pharmaceutical Industry Labor-Management Association
|
Flynn & Associates, Inc. | |||
Details Prescription drug industry issues relating to domestic employment and all other issues affecting the industry's U.S.workforce. |
Pharmaceutical Industry Labor Management Association
A labor-management association representing unions and pharmaceutical companies |
Flynn & Associates, Inc. | |||
Details Work to protect patent protections for pharmaceutical companies and other general issues relating to the Pharmaceutical Industry Work to protect patent protections for pharmaceutical companies and ... |
Pharmaceutical Industry Labor Management Association (PILMA)
|
Nelson, Mullins, Riley & Scarborough | |||
Details Price Controls, Intellectual Property Rights S.127 Pharmacy Benefit Manager Transparency Act S.113 S.1339 |
Pharmaceutical Industry Labor Management Association (PILMA)
|
The Mathis Harple Group | |||
Details Innovation Act--HR 9. A bill to promote transparency in patent ownership and make other improvements in the patent system. Entire bill. |
Pharmaceutical Industry Labor-Management Association
|
MR. MICHAEL L. TINER | |||
Details Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act o... |
Pharmaceutical Industry Labor Management Association
|
Mr. Patrick Foley | |||
Details Food and drug safety, generally. S. 1145, Patent Reform - section relating to penalties; |
Pharmaceutical Industry Labor Management Association (PILMA)
|
RON KLINK AND ASSOCIATES | |||
Details Issues related to IP protection under Bayh Dole; issues related to implementation of drug pricing and reimbursement for prescription drugs related to the Inflation Reduction Act of 2022 (PL 117-169). |
Pharmaceutical Industry Labor Management Association
|
Tiber Creek Group | |||
Details H.R. 976/H.R. 3973 - State Children's Health Insurance Program H.R. 3162 - State Children's Health Insurance Program S. 1893 - State Children's Health Insurance Program S. 1145 - Patent Reform Act ... |
Pharmaceutical Industry Labor-Management Association
|
Leary Ventures | |||
Details Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; |
Heinz Strategies LLC (on behalf of PILMA)
|
Mr. Patrick Foley | |||
Details Competition issues in the pharmacy benefit management industry. |
Pharmaceutical Care Management Association
|
The Gibson Group, LLC | |||
Details Television station carriage rights |
Community Broadcasters Association
The Association representing Class A and low power television stations |
RON KLINK AND ASSOCIATES | |||
Details FDA related issues; DTC advertizing follow on biologics-(biosimilars); Health care reform issues as they relate to pharmaceutical industry in general and sanofi-aventis in particular Manufacturing ... |
sanofi-aventis U.S. Inc.
|
PrO Unlimited | |||
Details Advocate on behalf of pharmaceutical benefit management practices impacted by direct and indirect remuneration and point of sale rebates related to the Medicare Part D prescription drug benefit pro... |
CVS Caremark
|
The D Major Group | |||
Details Issues relating to biodefense countermeasures and funding and continuous pharmaceutical manufacturing. Department of Defense Appropriations Act, FY2021, regarding appropriations, authorization and ... |
MACANDREWS SOUTH CORPORATION
|
in-house lobbying | |||
Details Renewable Fuel Standard implementation; Ethanol Industry updates; Ethanol infrastructure issues; Mid-level fuel blends; Small refinery waivers; Sustainable Aviation Fuel; H.R. 1608 - the Consumer a... |
RENEWABLE FUELS ASSOCIATION
|
in-house lobbying | |||
Details Issues related to FDA and HHS program funding for the FY24 Labor, HHS, Education and Related Agencies, and FY24 Agriculture, Rural Developments, Food, and Drug Administrations, and Related Agencies... |
GENENTECH, INC
|
in-house lobbying | |||
Details General budget, appropriations and education matters. |
Becker College
Budget, appropriations and education. |
The Normandy Group, LLC | |||
Details Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation H.R. 4818 Treat and Reduce Obesity Act |
Lilly USA, LLC
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details CBO modeling Drug Pricing Fiscal year 2024 Appropriations H.R. 5376, Inflation Reduction Act H.R. 6363, the Further Continuing Appropriations and Other Extensions Act, 2024 Importation Value of Med... |
NOVARTIS
|
in-house lobbying | |||
Details Issues related to pharmaceutical pricing; Legislation to incentivize new technology for innovation in home dialysis (no current bill number). Issues relating to drug pricing, home dialysis expansio... |
Baxter Healthcare Corporation
|
in-house lobbying | |||
Details H.R. 6363 Further Continuing Appropriations and Other Extensions Act of 2024 H.R. 5378 the Lower Costs, More Transparency Act S.3548 - Health Care Prices Revealed and Information to Consumers E... |
KAISER FOUNDATION HEALTH PLAN INC.
|
in-house lobbying | |||
Details H.R. 2670/S. 2226, National Defense Authorization Act for Fiscal Year 2024 H.R. 6131, Commercial Space Act of 2023 Draft legislation regarding Department of Commerce Office of Space Commerce missi... |
Chamber of Commerce of the U.S.A.
|
in-house lobbying | |||
Details Issues related to the Improving Seniors Timely Access to Care Act of 2021; Issues related to Pharmacy Direct and Indirect Remuneration (DIR), including the Contract Year (CY) 2023 Policy and Techni... |
The Cigna Group and subsidiaries (Formerly Cigna Corporation and subsidiaries)
|
in-house lobbying |